News

FBI investigating link between power morcellators and cancer risk


 

References

The FBI has launched an investigation into the use of power morcellators for hysterectomy, and is seeking information on what Johnson & Johnson knew about the use of the devices and the risk of spreading uterine sarcoma, according to a report in the Wall Street Journal.

According to the publication, FBI agents have “interviewed a retired pathologist who alerted [Johnson & Johnson] about potential problems with morcellators in 2006, a doctor who went public after her own cancer was worsened by the tool in 2013, and a California woman who has collected names of close to 400 patients and families of patients who may have been harmed by the tool.”

The Food and Drug Administration warned in November 2014 that power morcellators should not be used in the “vast majority” of women after 2 days of advisory committee hearings last July. Johnson & Johnson halted sales of its devices in July as well.

Read more at wsj.com (subscription required).

dfulton@frontlinemedcom.com

On Twitter @denisefulton

Recommended Reading

Avoiding “shotgun” treatment: New thoughts on endometriosis-associated pelvic pain
MDedge ObGyn
Endometriosis and pain: Expert answers to 6 questions targeting your management options
MDedge ObGyn
FDA requests more data on antiseptics used in health care settings
MDedge ObGyn
Spray-dried fibrin sealant for surgical use approved by FDA
MDedge ObGyn
Clinicians are adept at estimating uterine size prior to benign hysterectomy
MDedge ObGyn
Is the use of a containment bag at minimally invasive hysterectomy or myomectomy effective at reducing tissue spillage?
MDedge ObGyn
ACOG: Practice and referral patterns may affect occult uterine sarcoma risk post hysterectomy
MDedge ObGyn
FDA proposes 1-year blood donor deferral for gay and bisexual men
MDedge ObGyn
Putting isthmocele into perspective
MDedge ObGyn
Diagnosis and treatment of uterine isthmocele
MDedge ObGyn

Related Articles